Genital warts primary prevention: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 15: | Line 15: | ||
{{STD/STI}} | {{STD/STI}} | ||
{{Viral diseases}} | {{Viral diseases}} | ||
[[Category:Disease]] | |||
[[Category:Sexually transmitted diseases]] | [[Category:Sexually transmitted diseases]] |
Revision as of 13:20, 5 October 2012
Genital warts Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Genital warts primary prevention On the Web |
American Roentgen Ray Society Images of Genital warts primary prevention |
Risk calculators and risk factors for Genital warts primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Primary Prevention
Gardasil (sold by Merck & Co.) is a vaccine that protects against human papillomavirus types 16, 18, 6, and 11. Types 6 and 11 cause genital warts, while 16 and 18 cause cervical cancer. The vaccine is preventive, not therapeutic, and must be given before exposure to the virus type to be effective, ideally before the beginning of sexual activity. The vaccine is widely approved for use by young women, it is being tested for young men,[1] and has been approved for males in some areas, such as the UK.